Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48702
Campo DC Valoridioma
dc.contributor.authorAragón-Sánchez, Javieren_US
dc.contributor.authorLázaro-Martínez, Jose Luisen_US
dc.contributor.authorQuintana-Marrero, Yurenaen_US
dc.contributor.authorSanz-Corbalán, Ireneen_US
dc.contributor.authorHernández-Herrero, Maria J.en_US
dc.contributor.authorCabrera-Galván, Juan J.en_US
dc.date.accessioned2018-11-24T00:11:48Z-
dc.date.available2018-11-24T00:11:48Z-
dc.date.issued2013en_US
dc.identifier.issn1534-7346en_US
dc.identifier.urihttp://hdl.handle.net/10553/48702-
dc.description.abstractSurgery is usually used to treat diabetic foot osteomyelitis (DFO), whether primarily or in cases in which antibiotics are not able to control infection. In many cases, the bone is only partially removed, which means that residual infection remains in the bone margins, and the wound is left open to heal by secondary intent. The use of culture-guided postoperative antibiotic treatment and adequate management of the wound must be addressed. No trials exist dealing with local treatment in the postoperative management of these cases of complicated DFO. We decided to test a super-oxidized solution, Dermacyn Wound Care (DWC; Oculus Innovative Sciences Netherlands BV, Sittard, Netherlands) to obtain preliminary experience in patients in whom infected bone remained in the surgical wounds. Our hypothesis was that DWC could be useful to control infection in the residual infected bone and surrounding soft tissues and would thus facilitate healing. Fourteen consecutive patients who underwent conservative surgery for DFO, in whom clean bone margins could not be assured, were treated in the postoperative period with DWC. Eleven cases were located in the forefoot, 6 on the first ray and the rest in lesser toes, 1 in the Lisfranc joint, and 2 on the calcaneus. No side effects appeared during treatment. Neither allergies nor skin dermatitis were found. Limb salvage was successfully achieved in 100% of the cases. Healing was achieved in a median period of 6.8 weeks.en_US
dc.languageengen_US
dc.relation.ispartofInternational Journal of Lower Extremity Woundsen_US
dc.sourceInternational Journal of Lower Extremity Wounds[ISSN 1534-7346],v. 12, p. 130-137en_US
dc.subject32 Ciencias médicasen_US
dc.subject3205 Medicina internaen_US
dc.subject.otherSurgical-Treatmenten_US
dc.subject.otherInfectionsen_US
dc.subject.otherFeeten_US
dc.subject.otherEfficacyen_US
dc.subject.otherSafetyen_US
dc.subject.otherSeriesen_US
dc.subject.otherLimben_US
dc.titleSuper-oxidized solution (dermacyn wound care) as adjuvant treatment in the postoperative management of complicated diabetic foot osteomyelitis: Preliminary experience in a specialized departmenten_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1177/1534734613476710en_US
dc.identifier.scopus84879342680-
dc.identifier.isi000330520000007-
dc.contributor.authorscopusid6507768519-
dc.contributor.authorscopusid18434633300-
dc.contributor.authorscopusid24598202200-
dc.contributor.authorscopusid55556236600-
dc.contributor.authorscopusid24597529900-
dc.contributor.authorscopusid6602257053-
dc.description.lastpage137en_US
dc.description.firstpage130en_US
dc.relation.volume12en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid693544-
dc.contributor.daisngid832198-
dc.contributor.daisngid3382562-
dc.contributor.daisngid4370454-
dc.contributor.daisngid3160667-
dc.contributor.daisngid1841045-
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Aragon-Sanchez, J-
dc.contributor.wosstandardWOS:Lazaro-Martinez, JL-
dc.contributor.wosstandardWOS:Quintana-Marrero, Y-
dc.contributor.wosstandardWOS:Sanz-Corbalan, I-
dc.contributor.wosstandardWOS:Hernandez-Herrero, MJ-
dc.contributor.wosstandardWOS:Cabrera-Galvan, JJ-
dc.date.coverdateJunio 2013en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,41-
dc.description.jcr1,194-
dc.description.sjrqQ2-
dc.description.jcrqQ3-
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-6307-5040-
crisitem.author.orcid0000-0002-4184-6403-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameAragón Sanchez,Javier-
crisitem.author.fullNameCabrera Galván,Juan José-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

17
actualizado el 24-mar-2024

Citas de WEB OF SCIENCETM
Citations

20
actualizado el 25-feb-2024

Visitas

82
actualizado el 05-nov-2022

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.